Dose escalation of an Evans blue-modified radiolabeled somatostatin analog <sup>177</sup>Lu-DOTA-EB-TATE in the treatment of metastatic neuroendocrine tumors.

Liu, Qingxing; Cheng, Yuejuan; Zang, Jie; Sui, Huimin; Wang, Hao; Jacobson, Orit; Zhu, Zhaohui; Chen, Xiaoyuan

Dose escalation of an Evans blue-modified radiolabeled somatostatin analog ¹⁷⁷Lu-DOTA-EB-TATE in the treatment of metastatic neuroendocrine tumors.

Liu, Qingxing; Cheng, Yuejuan; Zang, Jie; Sui, Huimin; Wang, Hao; Jacobson, Orit; Zhu, Zhaohui; Chen, Xiaoyuan.

Afiliación

Liu Q; Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
Cheng Y; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, 100730, China.
Zang J; Oncology Department of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
Sui H; Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
Wang H; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, 100730, China.
Jacobson O; Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
Zhu Z; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, 100730, China.
Chen X; Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.

Eur J Nucl Med Mol Imaging ; 47(4): 947-957, 2020 04.

Article en En | MEDLINE | ID: mdl-31832728

Asunto(s)

Tumores Neuroendocrinos; Compuestos Organometálicos; Azul de Evans; Humanos; Tumores Neuroendocrinos/radioterapia; Octreótido/efectos adversos; Compuestos Organometálicos/efectos adversos; Tomografía Computarizada por Tomografía de Emisión de Positrones; Somatostatina/efectos adversos; Somatostatina/análogos & derivados

Palabras clave

177Lu-DOTA-EB-TATE; 177Lu-DOTATATE; Neuroendocrine tumor; Peptide receptor radionuclide therapy (PRRT)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Tumores Neuroendocrinos Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google